Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lovestone

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Biochemical Society Symposium|July 13, 2001
Apolipoprotein E gene and Alzheimer's disease: is tau the link?S Lovestone, B Anderton, J Betts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 28, 2001
Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variationC Holmes, H Smith, R Ganderton, et al.
Acta Neuropathologica|December 14, 1999
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortexD Cotter, M Honavar, S Lovestone, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinctC Strong, B H Anderton, R H Perry, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neuronsO V Forlenza, J M Spink, R Dayanandan, et al.
Biological Psychiatry|March 11, 1999
CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modificationJ A Cervilla, C Russ, C Holmes, et al.
British Journal of Pharmacology|November 13, 2001
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transportersC M Pariante, A Makoff, S Lovestone, et al.
FEBS Letters|January 6, 2000
The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activityK Leroy, R Menu, J L Conreur, et al.
Biological Psychiatry|March 12, 1998
Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's diseaseC Holmes, C Russ, G Kirov, et al.
Neuroscience|December 12, 2001
Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cellsT G Mack, R Dayanandan, M Van Slegtenhorst, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Biochemical Society Symposium|July 13, 2001
Apolipoprotein E gene and Alzheimer's disease: is tau the link?S Lovestone, B Anderton, J Betts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 28, 2001
Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variationC Holmes, H Smith, R Ganderton, et al.
Acta Neuropathologica|December 14, 1999
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortexD Cotter, M Honavar, S Lovestone, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinctC Strong, B H Anderton, R H Perry, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neuronsO V Forlenza, J M Spink, R Dayanandan, et al.
Biological Psychiatry|March 11, 1999
CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modificationJ A Cervilla, C Russ, C Holmes, et al.
British Journal of Pharmacology|November 13, 2001
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transportersC M Pariante, A Makoff, S Lovestone, et al.
FEBS Letters|January 6, 2000
The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activityK Leroy, R Menu, J L Conreur, et al.
Biological Psychiatry|March 12, 1998
Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's diseaseC Holmes, C Russ, G Kirov, et al.
Neuroscience|December 12, 2001
Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cellsT G Mack, R Dayanandan, M Van Slegtenhorst, et al.
Pageof 14